Delta-Sleep-Inducing Peptide (DSIP) is a widely investigated neuropeptide utilized in neurobiological, electroencephalographic, and endocrine research. For valid laboratory data, investigators require verified purity, strict batch traceability, and comprehensive analytical documentation. PX1 Research provides high-purity, USA-manufactured DSIP backed by lot-specific third-party testing.
Delta-Sleep-Inducing Peptide (DSIP) is a widely investigated neuropeptide utilized in neurobiological, electroencephalographic, and endocrine research. For valid laboratory data, investigators require verified purity, strict batch traceability, and comprehensive analytical documentation. PX1 Research provides high-purity, USA-manufactured DSIP backed by lot-specific third-party testing.
Lab-tested DSIP (Delta-Sleep-Inducing Peptide) is a synthetic, highly purified nonapeptide subjected to rigorous analytical verification—including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) purity analysis, Mass Spectrometry (MS) identity validation, and LAL endotoxin assays—to ensure exact chemical composition and lot-to-lot consistency for preclinical neurobiological, electroencephalographic, and stress-axis research.
Originally isolated from the cerebral venous blood of rabbits induced into slow-wave sleep, DSIP is an amphiphilic peptide consisting of nine amino acids: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. In preclinical settings, acquiring lab-tested DSIP research compound ensures that investigators evaluate pure peptide sequences without interfering trifluoroacetic acid (TFA) residual spikes, heavy metals, or bacterial lipopolysaccharide (LPS) contamination.
DSIP possesses a molecular formula of C35H48N10O15 and a molecular weight of approximately 848.81 g/mol. Its unique primary sequence contains a high proportion of glycine and alanine residues, providing structural flexibility, while the N-terminal tryptophan and C-terminal glutamic acid residues impart distinct spectral and charge properties during chromatography.
In laboratory solutions, the conformational state of DSIP depends heavily on pH, ionic strength, and solvent polarity. Because of its amphiphilic profile, unverified commercial preparations are prone to aggregation or rapid enzymatic cleavage if synthesized with minor sequence impurities. Preclinical laboratories routinely verify sequence fidelity through High-Resolution Mass Spectrometry (HRMS) to confirm that the monoisotopic mass matches theoretical values prior to initiating in vitro or animal models.
In preclinical literature, DSIP has been extensively studied for its capacity to alter electroencephalographic (EEG) patterns in rodent and non-human primate models. Early physiological trials demonstrated that central or systemic administration of low nanomolar quantities of DSIP promoted an increase in delta-wave activity (0.5–4 Hz frequency band), characteristic of deep, slow-wave sleep states.
Unlike conventional GABAergic sedatives, in vitro and ex vivo receptor assays indicate that DSIP does not bind directly to classic GABA-A or benzodiazepine binding sites. Instead, preclinical data suggest that DSIP modulates central monoaminergic transmission, downregulates phosphorylated protein kinase activity, and interacts with central NMDA receptor complexes to stabilize neuronal membrane potentials during rest-phase transitions.
Beyond central EEG effects, DSIP plays a distinct role in neuroendocrine signaling, particularly along the hypothalamic-pituitary-adrenal (HPA) axis. In animal models subjected to acute physical or environmental stressors, DSIP administration was observed to modulate adrenocorticotropic hormone (ACTH) secretion and attenuate stress-induced surges in systemic corticosterone levels.
Additionally, preclinical studies suggest that DSIP influences the release of luteinizing hormone (LH) and somatotropin (GH) in a basal state-dependent manner. By dampening hyper-activated stress cascades, the peptide aids in maintaining baseline physiological homeostasis during rest cycles, making it a valuable target for investigating stress recovery, circadian rhythm entrainment, and neurochemical stability.
When designing neurobiological or endocrine research protocols, scientists frequently compare DSIP to other central neuropeptides to establish baseline parameters for circadian or protective pathways. Below is a comparative overview of common neurological research compounds available across the comprehensive catalog of research peptides.
While DSIP primarily targets slow-wave sleep power spectra and HPA-axis normalization, compounds like Epithalon influence pineal gland activity and melatonin synthesis via telomerase-independent pineal signaling pathways. Meanwhile, synthetic neuropeptides such as Selank and Semax act predominantly as neurotrophic and anxiolytic modulators via BDNF and monoamine expression rather than direct delta-wave sleep induction. Utilizing verified, lab-tested iterations of each peptide allows research teams to map overlapping neuroendocrine feedback loops accurately.
Because synthetic peptides are subject to deletion sequences, incomplete coupling reactions, and counter-ion carryover, independent analytical verification is essential before deploying DSIP in cell culture or animal assays. At PX1 Research, every batch of DSIP undergoes rigorous analytical screening in ISO 17025 accredited testing facilities.
Verification mandates a three-part analytical protocol: RP-HPLC chromatography to confirm chemical purity (consistently target >98.0%), Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight and sequence identity, and Chromogenic LAL (Limulus Amebocyte Lysate) testing to ensure endotoxin levels remain strictly below <0.01 EU/mg. Every order is tied directly to a downloadable, lot-specific Certificate of Analysis (COA).
DSIP is delivered as a sterile, lyophilized cake to preserve chemical stability during transport and storage. To reconstitute the compound for in vitro or analytical assays, researchers should employ strict aseptic technique within a certified laminar flow hood.
Lyophilized DSIP exhibits high solubility in aqueous solutions. Reconstitution is typically performed using sterile laboratory-grade water or sterile bacteriostatic water depending on the assay duration. The diluent should be gently introduced along the inner glass wall of the vial, followed by low-speed swirl agitation. High-shear vortexing or violent shaking must be avoided to prevent mechanical shearing or surface-induced peptide aggregation.
Proper thermal management is imperative to prevent hydrolytic degradation or oxidation of the N-terminal tryptophan residue in DSIP. Lyophilized vials should be stored at -20°C for medium-term storage or -80°C for long-term preservation, kept dry and protected from direct ultraviolet light exposure.
Following reconstitution, liquid stock solutions maintain integrity at 2°C to 8°C for short experimental windows. For extended assay timelines, reconstituted solutions should be divided into single-use micro-aliquots using polypropylene cryogenic vials and stored at -80°C to eliminate repeated freeze-thaw cycles, which degrade peptide potency and alter chromatogram baselines.
Research integrity relies heavily on raw material consistency. Sourcing unverified peptides from overseas brokers or re-sellers who fail to provide lot-matched analytical testing introduces significant experimental confounders, including unrecorded impurities, heavy metal contamination, and variable salt forms.
Academic and commercial institutions managing bulk laboratory supply accounts require verifiable US manufacturing, ISO 17025 lab testing, and absolute lot traceability. PX1 Research synthesizes compounds in GMP-compliant facilities within the USA, ensuring that every batch meets standard analytical thresholds before publication-grade deployment.
Current preclinical investigations continue to expand beyond sleep architecture into broader neuroprotective and metabolic parameters. Recent animal studies indicate that DSIP may exert antioxidant activity by scavenging free radicals and protecting lipid membranes during ischemia-reperfusion models.
Furthermore, researchers are exploring the synergistic effects of DSIP combined with neurotrophic signaling factors to assess neuronal recovery after acute oxidative insults. As research protocols evolve, maintaining access to verified, lab-tested DSIP remains vital for obtaining reproducible, high-impact data across molecular biology and neurophysiology.
What does 'lab-tested DSIP' mean in a research context?
Lab-tested DSIP refers to Delta-Sleep-Inducing Peptide that has undergone independent third-party testing—such as RP-HPLC, Mass Spectrometry, and LAL endotoxin assays—to verify its precise sequence identity, purity percentage (>98%), and lack of biological or chemical contaminants prior to laboratory use.
What is the primary target studied in DSIP preclinical trials?
Preclinical studies focus on DSIP's capacity to induce slow-wave (delta-wave) sleep activity on electroencephalograms (EEG), modulate HPA-axis stress responses (specifically ACTH and corticosterone release), and reduce oxidative stress markers in tissue models.
How is DSIP purity verified at PX1 Research?
PX1 Research verifies DSIP quality via ISO 17025 accredited third-party laboratories using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity, Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular weight verification, and LAL assays for endotoxin quantification.
What solvent should be used to reconstitute DSIP for laboratory assays?
DSIP is typically reconstituted using sterile laboratory water, sterile 0.9% saline, or bacteriostatic water, depending on the specific in vitro or in vivo experimental setup. Reconstitution should be conducted using aseptic technique.
What is the correct storage temperature for lyophilized DSIP?
Lyophilized DSIP powder should be stored at -20°C for standard research timelines or -80°C for long-term preservation. Desiccated storage away from light prevents hydrolysis and tryptophan photo-oxidation.
What is the molecular weight and sequence of DSIP?
DSIP is a nonapeptide with the chemical sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and a molecular mass of 848.81 g/mol.
Does DSIP interact directly with GABA receptors?
In vitro binding assays demonstrate that DSIP does not bind directly to classical GABA-A or benzodiazepine binding sites; its central EEG effects appear mediated through complex monoaminergic and neuroendocrine regulatory pathways.
How can researchers access the lot-specific COA for PX1 Research DSIP?
Lot-specific Certificates of Analysis (COAs), showing full chromatograms, mass spectra, and endotoxin levels, are available directly through the PX1 Research online platform by matching the lot number on the product vial.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.